Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07612046 · ClinicalTrials.gov registry record
A Study of Magnetic Resonance Imaging of the Pancreas for Cancer Screening
A clinical trial, sponsored by Memorial Sloan Kettering Cancer Center.
- Recruiting
- Registry status
- 79
- Enrollment target
NCT07612046: Recruiting study, sponsored by Memorial Sloan Kettering Cancer Center.
NCT07612046 is a clinical trial that is actively recruiting participants, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 79 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07612046 is actively recruiting participants, sponsored by Memorial Sloan Kettering Cancer Center.
- RECRUITING
- Registry status
- 79 participants
- Enrollment target
Study Summary
The purpose of this study is to develop a dedicated MRI scan of the pancreas (MRP) to better detect pancreatic cancer in people who are at a high risk for pancreatic cancer.
Primary Outcome
Develop and pilot a focused high-resolution magnetic resonance pancreas (MRP) exam to help facilitate early pancreatic cancer detection in high-risk individuals. Image quality for T1, T2, and DWI sequences performed on the novel MRP exam will be compared to conventional MRCP performed in the same participants.
Interventions
- DIAGNOSTIC_TEST MRI
- DIAGNOSTIC_TEST Endoscopic ultrasound
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 79 participants |
| Start Date | 2026-05-20 |
| Est. Completion | 2028-05-20 |
What NCT07612046 shows while recruiting
NCT07612046 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 79 participants, a relatively small participant target.
The record links to 0 conditions, and to 2 interventions - of which MRI is the first listed.
NCT07612046 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07612046 about?
NCT07612046 is a clinical study titled "A Study of Magnetic Resonance Imaging of the Pancreas for Cancer Screening". The purpose of this study is to develop a dedicated MRI scan of the pancreas (MRP) to better detect pancreatic cancer in people who are at a high risk for pancreatic cancer.
What is the current status of trial NCT07612046?
This trial is currently recruiting. The enrollment target is 79 participants. The study started on 2026-05-20. Estimated completion is 2028-05-20.
What interventions are being tested in trial NCT07612046?
The interventions under investigation include: MRI (DIAGNOSTIC_TEST), Endoscopic ultrasound (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT07612046?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05798897 · 79 participants · Phase 1
Safety and Preliminary Efficacy of MT-601 in Patients With Relapsed/Refractory Lymphoma
- NCT06042439 · 79 participants · NA
AM vs PM Exercise Training
- NCT06223555 · 79 participants · NA
Variability In Mixed Meal Tests: Fixed Versus Adjusted to Energy Needs Caloric Dose
- NCT01243931 · 80 participants · NA
Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI